Published in Drugs on January 01, 1997
Nanomedicine--challenge and perspectives. Angew Chem Int Ed Engl (2009) 2.74
Targeting strategies for multifunctional nanoparticles in cancer imaging and therapy. Theranostics (2012) 2.35
Frontiers in cancer nanomedicine: directing mass transport through biological barriers. Trends Biotechnol (2010) 1.90
Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic. Crit Rev Ther Drug Carrier Syst (2009) 1.73
Overcoming platinum resistance in ovarian carcinoma. Expert Opin Investig Drugs (2010) 1.51
Hyaluronidase induces a transcapillary pressure gradient and improves the distribution and uptake of liposomal doxorubicin (Caelyx) in human osteosarcoma xenografts. Br J Cancer (2005) 1.29
Clinical potential of quantum dots. J Biomed Biotechnol (2007) 1.12
A novel peptide enhances therapeutic efficacy of liposomal anti-cancer drugs in mice models of human lung cancer. PLoS One (2009) 1.10
Liposome-encapsulated prednisolone phosphate inhibits growth of established tumors in mice. Neoplasia (2005) 1.07
Mind the gap: a survey of how cancer drug carriers are susceptible to the gap between research and practice. J Control Release (2013) 1.06
HER2-specific affibody-conjugated thermosensitive liposomes (Affisomes) for improved delivery of anticancer agents. J Liposome Res (2008) 1.05
Inhibition of the multidrug resistance P-glycoprotein: time for a change of strategy? Drug Metab Dispos (2014) 1.05
DESIGN OF LIPOSOMES CONTAINING PHOTOPOLYMERIZABLE PHOSPHOLIPIDS FOR TRIGGERED RELEASE OF CONTENTS. J Therm Anal Calorim (2009) 1.04
Basics and recent advances in peptide and protein drug delivery. Ther Deliv (2013) 0.98
Light-sensitive lipid-based nanoparticles for drug delivery: design principles and future considerations for biological applications. Mol Membr Biol (2010) 0.96
The clinical benefit of pegylated liposomal doxorubicin in patients with metastatic breast cancer previously treated with conventional anthracyclines: a multicentre phase II trial. Br J Cancer (2006) 0.96
Diamond-lipid hybrids enhance chemotherapeutic tolerance and mediate tumor regression. Adv Mater (2013) 0.94
Application of nanoparticles on diagnosis and therapy in gliomas. Biomed Res Int (2013) 0.91
Anthracycline rechallenge using pegylated liposomal doxorubicin in patients with metastatic breast cancer: a pooled analysis using individual data from four prospective trials. Br J Cancer (2010) 0.91
Surface engineering of liposomes for stealth behavior. Pharmaceutics (2013) 0.90
Exploiting endocytosis for nanomedicines. Cold Spring Harb Perspect Biol (2013) 0.89
Proteasome inhibitors block DNA repair and radiosensitize non-small cell lung cancer. PLoS One (2013) 0.88
Conjugation of quantum dots on carbon nanotubes for medical diagnosis and treatment. Int J Nanomedicine (2013) 0.88
Pilot study with pegylated liposomal doxorubicin for advanced or unresectable hepatocellular carcinoma. Br J Cancer (2001) 0.88
RNOP-09: pegylated liposomal doxorubicine and prolonged temozolomide in addition to radiotherapy in newly diagnosed glioblastoma--a phase II study. BMC Cancer (2009) 0.87
Nanotechnology: Future of Oncotherapy. Clin Cancer Res (2015) 0.86
Tuftsin augments antitumor efficacy of liposomized etoposide against fibrosarcoma in Swiss albino mice. Mol Med (2007) 0.86
Development and characterization of CD22-targeted pegylated-liposomal doxorubicin (IL-PLD). Invest New Drugs (2009) 0.85
Anthracycline Nano-Delivery Systems to Overcome Multiple Drug Resistance: A Comprehensive Review. Nano Today (2013) 0.84
Preparation, characterization and pharmacokinetics of folate receptor-targeted liposomes for docetaxel delivery. J Nanosci Nanotechnol (2009) 0.84
Combination therapy with gefitinib and doxorubicin inhibits tumor growth in transgenic mice with adrenal neuroblastoma. Cancer Med (2013) 0.84
Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come. Pharmacol Rev (2016) 0.84
Long-term pegylated liposomal doxorubicin use in recurrent ovarian carcinoma. J Natl Med Assoc (2005) 0.83
Lipid-based nanoparticles in cancer diagnosis and therapy. J Drug Deliv (2013) 0.83
Bioavailability of phytochemicals and its enhancement by drug delivery systems. Cancer Lett (2013) 0.81
Peptide-modified liposomes for selective targeting of bombesin receptors overexpressed by cancer cells: a potential theranostic agent. Int J Nanomedicine (2012) 0.81
Rapid determination of PEGylated liposomal doxorubicin and its major metabolite in human plasma by ultraviolet-visible high-performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci (2002) 0.80
Nanotechnology-Based Drug Delivery Systems for Melanoma Antitumoral Therapy: A Review. Biomed Res Int (2015) 0.79
Activity and safety of pegylated liposomal doxorubicin, 5-fluorouracil and folinic acid in inoperable hepatocellular carcinoma: a phase II study. World J Gastroenterol (2007) 0.78
Pharmacokinetics and antitumor efficacy of DSPE-PEG2000 polymeric liposomes loaded with quercetin and temozolomide: Analysis of their effectiveness in enhancing the chemosensitization of drug-resistant glioma cells. Int J Mol Med (2016) 0.77
The application of EDTA in drug delivery systems: doxorubicin liposomes loaded via NH4EDTA gradient. Int J Nanomedicine (2014) 0.77
Sustained liver targeting and improved antiproliferative effect of doxorubicin liposomes modified with galactosylated lipid and PEG-lipid. AAPS PharmSciTech (2010) 0.77
Multimodality imaging demonstrates trafficking of liposomes preferentially to ischemic myocardium. Cardiovasc Revasc Med (2016) 0.75
Inoculated Cell Density as a Determinant Factor of the Growth Dynamics and Metastatic Efficiency of a Breast Cancer Murine Model. PLoS One (2016) 0.75
The Emerging Role of Nanotechnology in Cell and Organ Transplantation. Transplantation (2016) 0.75
Advancements in the treatment of pediatric acute leukemia and brain tumor - continuous efforts for 100% cure. Korean J Pediatr (2014) 0.75
Iatrogenic Kaposi's sarcoma after immunosuppressive treatment for granulomatosis with polyangiitis (Wegener's). JAAD Case Rep (2015) 0.75
Advancements in the delivery of epigenetic drugs. Expert Opin Drug Deliv (2015) 0.75
Population pharmacokinetics of liposomal irinotecan in patients with cancer. Clin Pharmacol Ther (2017) 0.75
The efficacy and safety of pegylated liposomal doxorubicin monotherapy and combination therapy with carboplatin in Korean patients with recurrent ovarian, fallopian tube, or primary peritoneal cancer: a single-institution experience. Obstet Gynecol Sci (2017) 0.75
The genome of black cottonwood, Populus trichocarpa (Torr. & Gray). Science (2006) 21.03
Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochim Biophys Acta (1991) 4.16
454 Pyrosequencing analyses of forest soils reveal an unexpectedly high fungal diversity. New Phytol (2009) 4.04
INTESTINAL OBSTRUCTION DUE TO GALL-STONES: WITH REPORT OF THREE SUCCESSFUL CASES. Ann Surg (1912) 3.84
Tom40 forms the hydrophilic channel of the mitochondrial import pore for preproteins [see comment]. Nature (1998) 3.77
5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterology (1987) 3.35
Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes. Cancer Res (1994) 3.30
Cloning and expression of the human erythropoietin gene. Proc Natl Acad Sci U S A (1985) 3.28
Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation. J Biol Chem (1999) 2.86
Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responses. Eur J Immunol (1997) 2.77
IgMhighCD21high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells. J Immunol (1999) 2.73
Immune response in silico (IRIS): immune-specific genes identified from a compendium of microarray expression data. Genes Immun (2005) 2.69
Oral budesonide for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group. N Engl J Med (1994) 2.52
Laparoscopic treatment vs open surgery in the solution of major incisional and abdominal wall hernias with mesh. Surg Endosc (1999) 2.46
Demonstration of antigens related to colonic cancer in the human digestive system. Int J Cancer (1970) 2.35
Erroneous diagnosis of hemorrhage from esophageal varices. Am J Dig Dis (1969) 2.30
The transcriptome of the arbuscular mycorrhizal fungus Glomus intraradices (DAOM 197198) reveals functional tradeoffs in an obligate symbiont. New Phytol (2011) 2.29
The Tim core complex defines the number of mitochondrial translocation contact sites and can hold arrested preproteins in the absence of matrix Hsp70-Tim44. EMBO J (1997) 2.28
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol (2012) 2.17
Interventions to promote cancer awareness and early presentation: systematic review. Br J Cancer (2009) 2.14
Cortical motor reorganization in akinetic patients with Parkinson's disease: a functional MRI study. Brain (2000) 2.06
The active site of yeast aspartyl-tRNA synthetase: structural and functional aspects of the aminoacylation reaction. EMBO J (1994) 1.99
Replication-defective chimeric helper proviruses and factors affecting generation of competent virus: expression of Moloney murine leukemia virus structural genes via the metallothionein promoter. Mol Cell Biol (1987) 1.94
Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell (1994) 1.93
Evidence for selection of a population of multi-reactive B cells into the splenic marginal zone. Int Immunol (1997) 1.85
Nucleotide sequence analysis of a cDNA encoding human ubiquitin reveals that ubiquitin is synthesized as a precursor. J Biol Chem (1985) 1.77
Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells. J Biol Chem (1999) 1.73
Brief report: heavy-chain deposition disease. N Engl J Med (1993) 1.63
Constitutive activation of mitogen-activated protein kinase-activated protein kinase 2 by mutation of phosphorylation sites and an A-helix motif. J Biol Chem (1995) 1.62
Postentry restriction to human immunodeficiency virus-based vector transduction in human monocytes. J Virol (2001) 1.60
Oral contraceptive use and smoking are risk factors for relapse in Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group. Gastroenterology (1998) 1.48
Abnormal basement membrane in tumors induced by rat colon cancer cells. Gastroenterology (1994) 1.48
A human flora-associated rat model of the breast-fed infant gut. J Pediatr Gastroenterol Nutr (2003) 1.43
Transcription of osmB, a gene encoding an Escherichia coli lipoprotein, is regulated by dual signals. Osmotic stress and stationary phase. J Biol Chem (1990) 1.41
[First intention management of obstructive sleep apnea syndrome (OSAS) by custom-made mandibular advancement device: the medium-term results. Prospective study by the General Hospital Pneumologists College (CPHG)]. Rev Pneumol Clin (2010) 1.40
Protein kinase A and AP-1 (c-Fos/JunD) are induced during apoptosis of mouse mammary epithelial cells. Oncogene (1994) 1.39
[Association of celiac disease and antiphospholipid syndrome]. Presse Med (1998) 1.39
Frequency of obstructive sleep apnoea syndrome detected by means of a questionnaire in patients with coronary heart disease. Monaldi Arch Chest Dis (1995) 1.39
Sensitization of cancer cells treated with cytotoxic drugs to fas-mediated cytotoxicity. J Natl Cancer Inst (1997) 1.38
The aetiology of perforating ocular injuries in children. Br J Ophthalmol (2002) 1.37
Ubiquitinylation is not an absolute requirement for degradation of c-Jun protein by the 26 S proteasome. J Biol Chem (1995) 1.37
Parkinson's disease-associated alpha-synuclein is more fibrillogenic than beta- and gamma-synuclein and cannot cross-seed its homologs. J Biol Chem (2000) 1.35
Molecular basis of amplification in Drosophila phototransduction: roles for G protein, phospholipase C, and diacylglycerol kinase. Neuron (2002) 1.34
In vivo and in vitro invasiveness of a rat colon-cancer cell line maintaining E-cadherin expression: an enhancing role of tumor-associated myofibroblasts. Int J Cancer (1994) 1.33
Hemodynamic evaluation of patients with intrahepatic portal hypertension. Relationship between bleeding varices and the portohepatic gradient. Gastroenterology (1975) 1.32
Effective patient care in the pediatric ambulatory setting: a study of the acute care clinic. Pediatrics (1969) 1.32
Induction of interleukin-1 and tumor necrosis factor alpha in brain cultures by human immunodeficiency virus type 1. J Virol (1992) 1.32
Pantetheinase activity of membrane-bound Vanin-1: lack of free cysteamine in tissues of Vanin-1 deficient mice. FEBS Lett (2000) 1.32
Oral budesonide as maintenance treatment for Crohn's disease: a placebo-controlled, dose-ranging study. Canadian Inflammatory Bowel Disease Study Group. Gastroenterology (1996) 1.31
Role of stromal myofibroblasts infiltrating colon cancer in tumor invasion. Pathol Res Pract (1996) 1.29
Mouse CD38 is down-regulated on germinal center B cells and mature plasma cells. J Immunol (1997) 1.29
Identification of symbiosis-regulated genes in Eucalyptus globulus-Pisolithus tinctorius ectomycorrhiza by differential hybridization of arrayed cDNAs. Plant J (2001) 1.26
Secondary glaucoma after paediatric cataract surgery. Br J Ophthalmol (2007) 1.25
Ectomycorrhizin Synthesis and Polypeptide Changes during the Early Stage of Eucalypt Mycorrhiza Development. Plant Physiol (1991) 1.25
Radioimmunoassay of carcinoembryonic antigen in extracts of human colon and stomach. Int J Cancer (1972) 1.23
IHG-2, a mesangial cell gene induced by high glucose, is human gremlin. Regulation by extracellular glucose concentration, cyclic mechanical strain, and transforming growth factor-beta1. J Biol Chem (2000) 1.22
Specific roles of the alpha V beta 1, alpha V beta 3 and alpha V beta 5 integrins in avian neural crest cell adhesion and migration on vitronectin. Development (1994) 1.22
Outcomes in persistent hyperplastic primary vitreous. Br J Ophthalmol (2005) 1.22
Molecular links between mammary gland development and breast cancer. Cell Mol Life Sci (2007) 1.21
The mitochondrial Hsp70-dependent import system actively unfolds preproteins and shortens the lag phase of translocation. EMBO J (2001) 1.20
A role for calcium release-activated current (CRAC) in cholinergic modulation of electrical activity in pancreatic beta-cells. Biophys J (1995) 1.18
The mycorrhiza helper Pseudomonas fluorescens BBc6R8 has a specific priming effect on the growth, morphology and gene expression of the ectomycorrhizal fungus Laccaria bicolor S238N. New Phytol (2007) 1.17
Selection by trypsin of two sublines of rat colon cancer cells forming progressive or regressive tumors. Int J Cancer (1983) 1.17
Phylogenetic analysis, genomic organization, and expression analysis of multi-copper oxidases in the ectomycorrhizal basidiomycete Laccaria bicolor. New Phytol (2009) 1.17
Role of glycosylation on the secretion and biological activity of erythropoietin. Biochemistry (1992) 1.16
Adjuvant therapy of poor prognosis colon cancer with levamisole: results of an EORTC double-blind randomized clinical trial. Br J Surg (1989) 1.16
Germline transmission of exogenous genes in the chicken. Science (1989) 1.14
Sequencing the fungal tree of life. New Phytol (2011) 1.14
T-bet expression in intratumoral lymphoid structures after neoadjuvant trastuzumab plus docetaxel for HER2-overexpressing breast carcinoma predicts survival. Br J Cancer (2011) 1.14
Meiotic segregation and recombination of the intergenic spacer of the ribosomal DNA in the ectomycorrhizal basidiomycete Laccaria bicolor. Curr Genet (1996) 1.13
IL-18-binding protein protects against lipopolysaccharide- induced lethality and prevents the development of Fas/Fas ligand-mediated models of liver disease in mice. J Immunol (2001) 1.12
Role of dimerization in yeast aspartyl-tRNA synthetase and importance of the class II invariant proline. Proc Natl Acad Sci U S A (1993) 1.12
[Factors of early prognosis in medically treated haemorrhages of upper gastrointestinal tract in cirrhotic patients. Statistical study (author's transl)]. Pathol Biol (Paris) (1981) 1.12
Carcinoembryonic antigen (CEA) and related antigens in blood cells and hematopoietic tissues. Eur J Cancer (1975) 1.12
Therapy of primary and metastatic mouse mammary carcinomas with doxorubicin encapsulated in long circulating liposomes. Int J Cancer (1992) 1.11
Nonhematopoietic tumor cell lines express stem cell factor and display c-kit receptors. Blood (1992) 1.11
Cutting edge: the tumor counterattack hypothesis revisited: colon cancer cells do not induce T cell apoptosis via the Fas (CD95, APO-1) pathway. J Immunol (2000) 1.11
Tissue-specific expression of the platelet GPIIb gene. J Biol Chem (1991) 1.10
Biliary excretion and intestinal metabolism of progesterone and estrogens in man. J Steroid Biochem (1980) 1.10
A novel immunoglobulin superfamily junctional molecule expressed by antigen presenting cells, endothelial cells and platelets. Mol Immunol (1998) 1.09
Dual phosphorylation of the T-loop in cdk7: its role in controlling cyclin H binding and CAK activity. EMBO J (1997) 1.09
Tumor-infiltrating dendritic cells are defective in their antigen-presenting function and inducible B7 expression in rats. Int J Cancer (1997) 1.08
Bacteraemia in Dublin due to gentamicin-resistant Staphylococcus aureus. J Hosp Infect (1981) 1.07
Growth responses of rat stomach cancer cells to gastro-entero-pancreatic hormones. Int J Cancer (1982) 1.07
Liposomes can mimic virus membranes. Nature (1974) 1.06
ERalpha-CITED1 co-regulated genes expressed during pubertal mammary gland development: implications for breast cancer prognosis. Oncogene (2007) 1.06
Diadenosine polyphosphates. A novel class of glucose-induced intracellular messengers in the pancreatic beta-cell. Diabetes (1996) 1.06
Connective tissue growth factor [CTGF]/CCN2 stimulates mesangial cell migration through integrated dissolution of focal adhesion complexes and activation of cell polarization. FASEB J (2004) 1.05
Characterisation of functional inhibition of the glucocorticoid receptor by Fos/Jun. Oncogene (1991) 1.05
Phase II study of SPI-77 (sterically stabilised liposomal cisplatin) in advanced non-small-cell lung cancer. Br J Cancer (2006) 1.05
An experimental model for cancer of the colon and rectum. Intestinal carcinoma induced in the rat 1,2-dimethylhydrazine. Digestion (1973) 1.04
Expression of fibronectin ED-A+ and ED-B+ isoforms by human and experimental colorectal cancer. Contribution of cancer cells and tumor-associated myofibroblasts. Am J Pathol (1996) 1.03
Characterization and optimization of a real-time, parallel, label-free, polypyrrole-based DNA sensor by surface plasmon resonance imaging. Anal Chem (2000) 1.03
Cancer cell sensitization to fas-mediated apoptosis by sodium butyrate. Cell Death Differ (1998) 1.02
Laser beam wavefront correction for ultra high intensities with the 200 TW laser system at the advanced laser light source. Opt Express (2008) 1.02
Self-renewal and differentiation of normal avian erythroid progenitor cells: regulatory roles of the TGF alpha/c-ErbB and SCF/c-kit receptors. Cell (1993) 1.01
Placental changes and maternal weight in smoking and nonsmoking mothers. Am J Obstet Gynecol (1970) 1.01
YY1 and NF1 both activate the human p53 promoter by alternatively binding to a composite element, and YY1 and E1A cooperate to amplify p53 promoter activity. Mol Cell Biol (1996) 1.01
A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group. Gastroenterology (1997) 1.01